Anika Therapeutics (ANIK) Change in Receivables (2010 - 2026)
Anika Therapeutics (ANIK) posted quarterly Change in Receivables of $3.2 million for Q2 2026, up 35.92% year-over-year from $2.4 million in Q2 2025, and up 48.07% quarter-over-quarter from $2.2 million in Q1 2026.
Anika Therapeutics (ANIK) Change in Receivables (2010 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has reported Change in Receivables for 17 consecutive years, with $3.2 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Change in Receivables rose 35.92% year-over-year to $3.2 million; the TTM figure through Jun 2026 stood at $5.7 million (up 361.27% YoY), while the FY2025 annual figure was -$408000.0, up 87.88% from the prior year.
- Change in Receivables advanced to $3.2 million in Q2 2026 per ANIK's latest filing, from $2.2 million in the prior quarter.
- Across five years, Change in Receivables topped out at $6.2 million in Q2 2023 and bottomed at -$4.8 million in Q3 2024.
- Historically, Change in Receivables has averaged $476055.6 across 5 years, with a median of $1.3 million in 2023.
- Annual changes were most pronounced in 2023 — Change in Receivables tumbled 959.27% — and 2024, when it surged 196.38%.
- Anika Therapeutics' Change in Receivables stood at $647000.0 in 2022, then surged by 70.63% to $1.1 million in 2023, then soared by 196.38% to $3.3 million in 2024, then slumped by 52.78% to $1.5 million in 2025, then soared by 108.93% to $3.2 million in 2026.
- Business Quant data shows ANIK's Change in Receivables at $3.2 million in Q2 2026, $2.2 million in Q1 2026, and $1.5 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 91.00 Mn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 66.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -445.26 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | -1.70 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 126.50 Mn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 84.30 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Anika Therapeutics | 282.86 Mn | 244.45 Mn | 21.24 Mn | 3.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.23 Mn |
| Jun 30, 2026 | 3.23 Mn |
| Mar 31, 2026 | 2.18 Mn |
| Mar 31, 2026 | 2.18 Mn |
| Dec 31, 2025 | 1.55 Mn |
| Dec 31, 2025 | 1.55 Mn |
| Sep 30, 2025 | -1.29 Mn |
| Sep 30, 2025 | -1.29 Mn |
| Jun 30, 2025 | 2.38 Mn |
| Jun 30, 2025 | 2.38 Mn |
| Mar 31, 2025 | -3.03 Mn |
| Mar 31, 2025 | -3.03 Mn |
| Dec 31, 2024 | 3.27 Mn |
| Dec 31, 2024 | 3.27 Mn |
| Sep 30, 2024 | -4.78 Mn |
| Sep 30, 2024 | -4.78 Mn |
| Jun 30, 2024 | 1.77 Mn |
| Jun 30, 2024 | 1.77 Mn |
| Mar 31, 2024 | -3.62 Mn |
| Mar 31, 2024 | -3.62 Mn |